140 related articles for article (PubMed ID: 29384367)
1. Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs.
Forte N; Livanos M; Miranda E; Morais M; Yang X; Rajkumar VS; Chester KA; Chudasama V; Baker JR
Bioconjug Chem; 2018 Feb; 29(2):486-492. PubMed ID: 29384367
[TBL] [Abstract][Full Text] [Related]
2. Tuning the Diels-Alder Reaction for Bioconjugation to Maleimide Drug-Linkers.
St Amant AH; Lemen D; Florinas S; Mao S; Fazenbaker C; Zhong H; Wu H; Gao C; Christie RJ; Read de Alaniz J
Bioconjug Chem; 2018 Jul; 29(7):2406-2414. PubMed ID: 29932647
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides.
Christie RJ; Fleming R; Bezabeh B; Woods R; Mao S; Harper J; Joseph A; Wang Q; Xu ZQ; Wu H; Gao C; Dimasi N
J Control Release; 2015 Dec; 220(Pt B):660-70. PubMed ID: 26387744
[TBL] [Abstract][Full Text] [Related]
4. Optimised approach to albumin-drug conjugates using monobromomaleimide-C-2 linkers.
Wall A; Nicholls K; Caspersen MB; Skrivergaard S; Howard KA; Karu K; Chudasama V; Baker JR
Org Biomol Chem; 2019 Aug; 17(34):7870-7873. PubMed ID: 31410415
[TBL] [Abstract][Full Text] [Related]
5. Impact of Site-Specific Conjugation of ScFv to Multifunctional Nanomedicines Using Second Generation Maleimide.
Hervé-Aubert K; Allard-Vannier E; Joubert N; Lakhrif Z; Alric C; Martin C; Viaud-Massuard MC; Dimier-Poisson I; Aubrey N; Chourpa I
Bioconjug Chem; 2018 May; 29(5):1553-1559. PubMed ID: 29553717
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Disulfide Bond Rebridged Fab-Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload.
Ruddle BT; Fleming R; Wu H; Gao C; Dimasi N
ChemMedChem; 2019 Jun; 14(12):1185-1195. PubMed ID: 30980702
[TBL] [Abstract][Full Text] [Related]
7. Bioconjugation of Antibodies to Horseradish Peroxidase (HRP).
Hnasko RM
Methods Mol Biol; 2015; 1318():43-50. PubMed ID: 26160562
[TBL] [Abstract][Full Text] [Related]
8. Site-Specific Conjugation of Auristatins onto Engineered scFv Using Second Generation Maleimide to Target HER2-positive Breast Cancer in Vitro.
Aubrey N; Allard-Vannier E; Martin C; Bryden F; Letast S; Colas C; Lakhrif Z; Collinet N; Dimier-Poisson I; Chourpa I; Viaud-Massuard MC; Joubert N
Bioconjug Chem; 2018 Nov; 29(11):3516-3521. PubMed ID: 30352511
[TBL] [Abstract][Full Text] [Related]
9. Improving the serum stability of site-specific antibody conjugates with sulfone linkers.
Patterson JT; Asano S; Li X; Rader C; Barbas CF
Bioconjug Chem; 2014 Aug; 25(8):1402-7. PubMed ID: 25099687
[TBL] [Abstract][Full Text] [Related]
10. Improved tumor targeting with chemically cross-linked recombinant antibody fragments.
King DJ; Turner A; Farnsworth AP; Adair JR; Owens RJ; Pedley RB; Baldock D; Proudfoot KA; Lawson AD; Beeley NR
Cancer Res; 1994 Dec; 54(23):6176-85. PubMed ID: 7954464
[TBL] [Abstract][Full Text] [Related]
11. CBTF: new amine-to-thiol coupling reagent for preparation of antibody conjugates with increased plasma stability.
Kolodych S; Koniev O; Baatarkhuu Z; Bonnefoy JY; Debaene F; Cianférani S; Van Dorsselaer A; Wagner A
Bioconjug Chem; 2015 Feb; 26(2):197-200. PubMed ID: 25614935
[TBL] [Abstract][Full Text] [Related]
12. Bioconjugation with Maleimides: A Useful Tool for Chemical Biology.
Ravasco JMJM; Faustino H; Trindade A; Gois PMP
Chemistry; 2019 Jan; 25(1):43-59. PubMed ID: 30095185
[TBL] [Abstract][Full Text] [Related]
13. Efficient and irreversible antibody-cysteine bioconjugation using carbonylacrylic reagents.
Bernardim B; Matos MJ; Ferhati X; Compañón I; Guerreiro A; Akkapeddi P; Burtoloso ACB; Jiménez-Osés G; Corzana F; Bernardes GJL
Nat Protoc; 2019 Jan; 14(1):86-99. PubMed ID: 30470819
[TBL] [Abstract][Full Text] [Related]
14. Structural investigation of cyclo-dioxo maleimide cross-linkers for acid and serum stability.
Tobaldi E; Dovgan I; Mosser M; Becht JM; Wagner A
Org Biomol Chem; 2017 Nov; 15(44):9305-9310. PubMed ID: 29077116
[TBL] [Abstract][Full Text] [Related]
15. A Reactive Antibody Platform for One-Step Production of Antibody-Drug Conjugates through a Diels-Alder Reaction with Maleimide.
St Amant AH; Huang F; Lin J; Lemen D; Chakiath C; Mao S; Fazenbaker C; Zhong H; Harper J; Xu W; Patel N; Adams L; Vijayakrishnan B; Howard PW; Marelli M; Wu H; Gao C; Read de Alaniz J; Christie RJ
Bioconjug Chem; 2019 Sep; 30(9):2340-2348. PubMed ID: 31380623
[TBL] [Abstract][Full Text] [Related]
16. Specific Conjugation of the Hinge Region for Homogeneous Preparation of Antibody Fragment-Drug Conjugate: A Case Study for Doxorubicin-PEG-anti-CD20 Fab' Synthesis.
Zhou Z; Zhang J; Zhang Y; Ma G; Su Z
Bioconjug Chem; 2016 Jan; 27(1):238-46. PubMed ID: 26700095
[TBL] [Abstract][Full Text] [Related]
17. Rapid Evaluation of Antibody Fragment Endocytosis for Antibody Fragment-Drug Conjugates.
Kim EG; Jeong J; Lee J; Jung H; Kim M; Zhao Y; Yi EC; Kim KM
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32630402
[TBL] [Abstract][Full Text] [Related]
18. Minireview: Addressing the retro-Michael instability of maleimide bioconjugates.
Szijj PA; Bahou C; Chudasama V
Drug Discov Today Technol; 2018 Dec; 30():27-34. PubMed ID: 30553517
[TBL] [Abstract][Full Text] [Related]
19. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.
Shen BQ; Xu K; Liu L; Raab H; Bhakta S; Kenrick M; Parsons-Reponte KL; Tien J; Yu SF; Mai E; Li D; Tibbitts J; Baudys J; Saad OM; Scales SJ; McDonald PJ; Hass PE; Eigenbrot C; Nguyen T; Solis WA; Fuji RN; Flagella KM; Patel D; Spencer SD; Khawli LA; Ebens A; Wong WL; Vandlen R; Kaur S; Sliwkowski MX; Scheller RH; Polakis P; Junutula JR
Nat Biotechnol; 2012 Jan; 30(2):184-9. PubMed ID: 22267010
[TBL] [Abstract][Full Text] [Related]
20. A robust method for the preparation and purification of antibody/streptavidin conjugates.
Hylarides MD; Mallett RW; Meyer DL
Bioconjug Chem; 2001; 12(3):421-7. PubMed ID: 11353541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
